Delivery Order SPE2DB22D2006-SPE2DB24FW3CL
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$54K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $25,814.16 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, including the military. This contract is part of a larger Indefinite Delivery Contract...
This is a $36,781.92 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance through May 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,265.40 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product and has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This is a $3,026.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product. It does not have a set-aside designation. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,250,565 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL) with a potential value of $2,251.46. The delivery order has a completion date of January 8, 2024 and was awarded on January 5, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office...
This is a $4,085.47 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide BOOSTRIX TDAP vaccine syringes. The contract has an ultimate completion date of July 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which enables the DLA to efficiently procure a...
This is a $6,304.42 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Boostrix TDAP vaccine syringes. The contract has an ultimate completion date of May 20, 2025 and is not set aside. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including a $999,999,999.00 Indefinite...
This is a $121,212.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,026.15 order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, to be delivered by March 8, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $1,494.16, is for the delivery of BOOSTRIX TDAP vaccine syringes. This order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...